A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis
Clinical trial NCT01011309 · COMPLETED
Trial details
- NCT number
- NCT01011309
- Sponsor
- Access to Advanced Health Institute (AAHI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2011-05-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.